Company profilePharmaceutical#879 of 1,318 in Pakistan✓ No DRAP alerts

GENOME PHARMA DSL: DHO-ISB-2257

Pharmaceutical company · 7 brands · 10 molecules

7 registered products 10 pharmaceutical brands 10 distinct molecules 0 DRAP alerts

Company overview

7
registered products
10
pharmaceutical brands
10
distinct molecules
0
therapeutic classes
0
DRAP alerts

GENOME PHARMA DSL: DHO-ISB-2257 is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 7 product registrations across 10 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by GENOME

8 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

7
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
20257

Top molecules by brand count

Oxaliplatin ...... 100 Mg1 brand
Oxaliplatin .... 50Mg1 brand
Sevoflurane ...... 100 %1 brand
Gemcitabine ...... 200 Mg1 brand
Gemcitabine ...... 1000 Mg1 brand
Heparin Sodium ...... 25000 Iu1 brand
Heparin1 brand
Anastrozole ...... 1 Mg1 brand
Zoledronic Acid ...... 4 Mg1 brand
Calcium Folinate Folinic Acid ...... 50 Mg1 brand

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official9 products · Rs 912.37 – Rs 37,002.09
Median across source: Rs 11,978.45

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

AbirateroneAceclofenacBicalutamideBortezomibCarboplatinIrinotecan 20Mg
HAKIMSONS IMPEX (PVT) LTD. holds 7 molecules not in this portfolio
Anti D ImmunoglobulinAnti-D ImmunoglobulinBicalutamideCapecitabineDocetaxelHuman Albumin
MACTER INTERNATIONAL (PVT) LTD. holds 176 molecules not in this portfolio
000 I.U10Ug Polysaccharides Covalently Bound To 20Ug To 32Ug Of Tetanus ToxoidAlbendazoleAlbuterolAlfacalcidolAluminium Hydroxide

Get the full profile for GENOME

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.